메뉴 건너뛰기




Volumn 46, Issue 8, 2012, Pages 627-628

Mycobacterium avium subspecies paratuberculosis in Crohn's disease: The puzzle continues

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CLARITHROMYCIN; CLOFAZIMINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MACROLIDE; MERCAPTOPURINE; RIFABUTIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

EID: 84865479129     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182621ed4     Document Type: Editorial
Times cited : (9)

References (7)
  • 1
    • 84865469648 scopus 로고    scopus 로고
    • Mycobacterium avium ss paratuberculosis-associated diseases; piecing the Crohn's puzzle together
    • Gitlin L, Borody TJ, Chamberlin W, et al. Mycobacterium avium ss paratuberculosis-associated diseases; piecing the Crohn's puzzle together. J Clin Gastroenterol. 2012;46:649-655.
    • (2012) J Clin Gastroenterol , vol.46 , pp. 649-655
    • Gitlin, L.1    Borody, T.J.2    Chamberlin, W.3
  • 2
    • 9244261648 scopus 로고    scopus 로고
    • Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis
    • Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol. 2004;58:329-363.
    • (2004) Annu Rev Microbiol , vol.58 , pp. 329-363
    • Chacon, O.1    Bermudez, L.E.2    Barletta, R.G.3
  • 3
    • 84865469713 scopus 로고    scopus 로고
    • Immunologic basis for extraintestinal manifestations in inflammatory bowel disease
    • Das KM. Immunologic basis for extraintestinal manifestations in inflammatory bowel disease. UpToDate. 2011.
    • (2011) UpToDate.
    • Das, K.M.1
  • 4
    • 34547934812 scopus 로고    scopus 로고
    • Mycobacterium avium subspecies paratuberculosis and Crohn's disease: A systemic review and meta-analysis
    • Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: A systemic review and meta-analysis. Lancet Infect Dis. 2007;7:607-613.
    • (2007) Lancet Infect Dis , vol.7 , pp. 607-613
    • Feller, M.1    Huwiler, K.2    Stephan, R.3
  • 5
    • 36549017255 scopus 로고    scopus 로고
    • The evidence for Mycobacterium paratuberculosis in Crohn's disease
    • Behr MA, Kapur V. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr Opin Gastroenterol. 2008; 24:17-21.
    • (2008) Curr Opin Gastroenterol , vol.24 , pp. 17-21
    • Behr, M.A.1    Kapur, V.2
  • 6
    • 34250030068 scopus 로고    scopus 로고
    • Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
    • The Antibiotics in Crohn's Disease Study Group
    • Selby W, Pavli P, Crotty B, et al. The Antibiotics in Crohn's Disease Study Group. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology. 2007;132:2513-2519.
    • (2007) Gastroenterology , vol.132 , pp. 2513-2519
    • Selby, W.1    Pavli, P.2    Crotty, B.3
  • 7
    • 43849087155 scopus 로고    scopus 로고
    • Antimicrobial therapy for Crohn's disease: A reanalysis
    • Behr MA, Hanley J. Antimicrobial therapy for Crohn's disease: A reanalysis. Lancet Infect Dis. 2008;8:344.
    • (2008) Lancet Infect Dis , vol.8 , pp. 344
    • Behr, M.A.1    Hanley, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.